Day 1, Part 5: PTAC Public Meeting | PTAC Recommendations Committee Discussion| September 14, 2026 | 5/7
The Physician-Focused Payment Model Technical Advisory Committee (PTAC) held a 2-day meeting on PTAC Recommendations for Transforming Health Care Delivery Through Value-Based Care.
Additional information about PTAC: Physician-Focused Payment Model Technical Advisory Committee (PTAC) | ASPE (hhs.gov) -- U.S. Department of Health and Human Services (HHS) | http://www.hhs.gov | HHS Privacy Policy | http://www.hhs.gov/Privacy.html
PTAC Members: Co-Chairs Terry (Lee) L. Mills, Jr., MD, MMM Soujanya (Chinni) R. Pulluru, MD Members Henish Bhansali, MD, FACP Lindsay K. Botsford, MD, MBA Lauran Hardin, MSN, FAAN Lawrence R. Kosinski, MD, MBA Joshua M. Liao, MD, Msc Walter Lin, MBA Krishna Ramachandran, MBA, MS David C. Tyson, MA ---
U.S. Department of Health and Human Services (HHS)
http://www.hhs.gov HHS Privacy Policy
AI Generated·May contain errors
Video Summary
AI Generated
The ETAC committee discussed refining a white paper on Value-Based Care (VBC), focusing on reducing administrative friction and tailoring payment models to geographic needs. The conversation emphasized simplifying quality metrics, addressing the resource gap for rural providers, and balancing the trade-off between actuarial fairness and operational simplicity to improve healthcare affordability.
Welcome back.
ETAC convened this public meeting to obtain input on its draft
white paper recommendations on value-based care.
We now have time for the committee to reflect on what we've learned today
from today's lessons and to consider areas for
revising the white paper. We will hear from more experts tomorrow,
but we want to take the time to gather our thoughts now before adjourning for the day.
Committee members, I'm going to ask you
to refer to the potential topics for discussion document during this discussion.
To indicate that you have a comment, please flip your name
card up, and for our virtual committee members, please raise your hand on Zoom.
Who would like to start? Lauren.
I'm going to dive in because I have a mediated comment.
This was a really, really valuable day. The richness of the speakers,
the diversity of their expertise, and how deeply they understood
this document and their historical
connection with value-based payment was so valuable today.
I feel like I really need to read the transcript to completely
take it in and look at it side by side with the actual document.
Some of the themes I heard today, the importance of flexibility.
Overall, the general comment was
this document was on target but maybe needs to go further.
Elizabeth's comment is resonating in my ears.
We have five years left to move the dial on delivery
because of the complexity and difficulty of what's happening
for people directly with care, but also
that it's not a sustainable situation for changes to happen.
We heard a lot of interesting
I heard some things that I thought we need to
go back and look at, emphasizing even more,
which is the integration of behavioral health, health-related social needs,
and really thinking about maybe another level
deep around the diversity of what needs to be provided for
rural success versus urban.
Then Jennifer said something that I thought was really
striking is that we have to
plan for the lack of change.
We have to design in the dollars for that, the attention
for that, and someone to hold that centralized infrastructure.
We started to hear a little bit about hubs, we heard a little bit about
incentive dollars, maybe for leaders to pull things together to have a
sustainable system, but paying attention to that.
I will leave it there and say I really want to go deeper
with the transcripts.
Thank you, Lauren. Krishna?
Yeah, Lauren, I thought it was a super helpful day.
Really great to see the perspectives from across the section.
It was a great job to all of you as well for the
recommendations and speakers. I thought we had people with
such breadth and depth of value-based care. Obviously they brought their
very different lived experiences into the mix, and so certainly their comments
reflected some of the variations as well and some of the tensions
that came about, right, if we mandate or not, and describe this,
be flexible here, give us room, but fix
the benchmarks and align our measures. The tensions were clear, but
it's all coming from people's very valid and genuine
lived experiences as well. A few takeaways for me from a
white paper perspective. One was on just Medicare Advantage,
making sure that we factored that in. Obviously our broader
charter includes models beyond traditional Medicare, so I thought that was
a helpful reminder for us to take a look and see if we need
to change anything in the white paper related to that.
Member incentives, so benefit design to further value-based care, I think
is an important third leg of the stool. Much of the
BBC conversation has been on payer-provider alignment, so
the people that pay the bills and the people that deliver care, and so
Sean brought up the comments on member incentives
and co-pay waivers, and so those are important elements
in our mix. Certainly data interoperability, strengthening
and sharpening the pen on the white paper on that, I think is a takeaway
for us. Conveners and what it means
for other stakeholders, I think where
they're applicable, I think incorporating those as well into our white paper.
And then a conversation we were having on just residence, training,
graduate student type aspects, and what it means for
our workforce as another element.
Lee? Yeah, really, really
rich day of conversation.
Some themes that we heard reflected over and over is about
sense of, you know, express different ways
but sense of pressure, sense that things need to
go faster, not slower. Definitely a lot of talk about
reducing, as opposed to building incentives or new payment models, we heard lots about just
using policy authority to reduce friction, make it easier to
get clarity, join a model,
to deal with the metrics, deal with the rules, that sort of thing.
That certainly seems possible. Heard a lot about
prospective payments, and both
Sean and Jennifer this morning spoke to that in conversation after I
asked them, you know, what percent of
total payment should be prospective across different areas, and you know, they were both
on the line saying, you know, for rural areas, we just need to get them resources.
So they'd say, you know, 90% plus total expected payment
actually should be prospective to rural areas, and
you know, independence in non-rural areas,
not in systems maybe as high as 60%, which is
when you talk to plans doing prospective payment
for value-based contracts, if there was any prospective payment at all,
it's usually less than 10%. There seems like there's a vast gulf
between what the wider community is saying needs to be paid prospectively and what the
employer and plan community is saying, and so there's something there to
unpack and think through.
And really interesting statements here, most recently
about that, you know, transparency is well and good, and everybody
says they want more transparency, and they kind of have that mixed up in their mind
by fairness, but yet transparency around risk adjustment
has not been useful in any of the outcomes, and it just leaves providers
to obsess in chasing risk adjustment in some
system if they get good at it. And of course, there's a whole vendor ecology around
risk adjustment in other venues that have problems, and so
consider, I think her statement, what I wrote down was, consider I'd be happier with
a fair black box than the system now, risk adjustment
now, which is really fascinating. The statement this afternoon about
waiting for independent or rural providers to join
voluntarily and just figure out value-based care is magical thinking,
and that really struck with me. It's really,
it probably isn't about incentives for rural providers
because it's just too hard to join and figure it out.
They don't have any time, bandwidth, or resources to figure it out. They're going to keep
riding the truck they're on, and so of the arguments for
a glide path towards mandatory, I heard
it applied to actually the rural group, which is the group I
had in my head was more voluntary.
I may have more later on. I'll pass for now.
Lindsay? Thanks, Jenny.
I mean, I think we heard themes that we've heard in other meetings, the importance of removing
friction, simplifying.
I think there's a couple things that I heard in the speakers
that are maybe tweaks on things we've heard before.
The idea of rewarding longevity on plan,
both potentially for the beneficiary and the
provider as well, and I think just generally the idea
of developing more incentives instead of just sticks,
especially incentives at the consumer level,
such as the co-insurance or co-pay waivers,
and then incentivizing primary care and preventive services, as well as
high-performing specialists, I think was mentioned too.
How can we make it financially beneficial
for the patient to make the right choice and make it easy to do the right thing?
A couple things around model testing that
were interesting, one around
maybe it's not what new model we need,
but what we need to take away or reduce from existing
models and just simplify, or have less models
in general. I think
coalescing questions around whether the quality measures
we're using right now are getting us the right outcomes that we want,
and I think especially some of the conversations
around could quality measures function
more to focus on the bottom and making sure someone is not bad
as opposed to ensuring a certain level of
how good they are. We heard multiple times
the needs of rural areas. I think the interesting part was more
around this isn't a payment model for rural, this is just more
for payment, and that payment needs to be different for
people in isolation, sometimes regardless just of the geographic
practice setting. And then as far
as the model testing, I think interesting
points around maybe we don't want to show a cost
savings in primary care. Maybe that's preventing us
from testing important things in terms of what investment can do
that's not going to reap benefits during a testing period.
I think a couple things that have been hit on that are less clear that remain
in payment models but could be laying the groundwork for
more value-based care, the interoperability and data
sharing, less clear if that's really in a payment model or just needs to be
in the infrastructure that exists to make value-based
care happen. And then similarly, I think
again, outside of a payment model, but we heard flexibility
in terms of mode and modality of service from multiple
of our speakers, and so things like extension of telehealth
flexibilities would also support some of the things that we've heard that are
essential to driving value. I think that's all for now.
Thank you. Walter? So my fellow committee
members have covered a lot of ground, which I won't repeat.
I think one of the things that struck me the most about today
was this whole whiplash we've had around whether we
should be mandating models or not.
This morning it was definitely no mandates, and this
afternoon it was very much go mandatory models.
I think maybe how I'm reconciling this in my head
is what Sean Martin said about how
well-designed models shouldn't need to be mandatory.
And there's some discussion around how
Medicare Advantage is the kind of clearest example
of that proposition. I guess in my mind
I'm not sure that's really a good example because a lot
of experts would argue that Medicare Advantage has grown so much
because it is paid more than traditional Medicare
rather than being better designed. But I think there are some probably
lessons that traditional Medicare can take from Medicare
Advantage and
incorporate it. And we spoke about some of the
models that Optum has around the care of
the seriously ill and chronically complex. That makes a lot of
sense. And then the other thing
that struck me about Medicare Advantage, I didn't expect this session to be so much
about Medicare Advantage, but Mike Chernew started out
by saying we need to reform Medicare Advantage, otherwise it's going to swamp
APMs and traditional
Medicare. And I think that's a good word of caution
to reiterate. Other things that struck
me from today, the whole discussion around
quality. Maybe we've kind of gotten
off track a bit with the current
focus on quality metrics. I didn't really expect
Mike and Sean to say what they said around
maybe we don't need to look at quality the way
we're looking at quality now. Maybe the total cost of care
can
in large part, and I don't want to put words in their mouth, but I
think they said in large part obviate the need to have a focus on
quality metrics. And then lastly
I think what Mike said around
the Medicare physician fee schedule being a value-based
payment model in and of itself is super important. I know we've discussed this
amongst the committee somewhat in terms of the need to reform
the physician fee schedule because even under
the most value-based care models,
most blue blood value-based care models, the fee schedule
still plays a very important role in terms of
incentivizing volume of care and
service mix. I want to just
pick up on what Walter just said about
quality and it was really kind of the first time I really heard that. The drive
for reduced friction and simplicity and the dangers
of measuring the wrong stuff has gotten so bad
that actually in little evidence
that the rush to move quality measures higher is actually changing the care
fundamentally. Actually we have to go the opposite direction and simplify and just
use quality measures to ensure in a total cost of care system that people aren't getting
bad. We should measure the low side and not worry and adjust
for it somehow or have negative incentives but not worry
about trying to incent good to great. That makes sense mathematically
your best gain is poor to average not average to good.
That was interesting. I'll pick up a few more threads which was
a really good conversation in our first panel about technology and is it
a tool? Is it a partner? Is it
a model? Should it be separately paid or is it just expected
the practice will use the technology they need for the model they're a part of?
I really think we need to pull that thread a bit more and have some recommendations
about what we've heard about.
I feel like I react negatively to technology or
AI tools for clarity at the point of care. Any of that it should be its own model.
I think to some degree anything that we would
frame up, model out and value and build a model around
is going to be obsolete before we could ever get it on the system. So it's more like
smart use of technology hooked up to your data or point of care systems
to drive better outcomes is just expected. That's table stakes already.
Technology is an enabler and it's a partner
and it's a tool but it's really not a model. I'd like to take a stand on that a little bit.
I really heard a fascinating sentence I've never quite heard
before. I'm forgetting who said it about that we can either be
fair or we can be simple but not fair.
Maybe the pendulum has swung too far and as
I'm busy trying to write value-based models and contracts
and specify out all the ways it's fair for providers
and manage Medicaid. Right now I'm really seeing that live out
that providers don't trust us. They want to see spelled out all the math
but when you ask the actuaries to spell out the math it gets so incredibly
complicated about what's going to happen and how the trip's going to work 36 months from
now that it literally can't be operated. There's something
real that we have to really double-click on and then lastly
I was really struck by this last panel that
value-based care has a brand in the policy
and legislative world when you say value-based care it
dissolves, it immediately fragments into two dozen different
perspectives and passionate arguments for policy and legislative types
about whether it's good, it's bad, it's this type or that type and
to the wider audience and public value-based care just means
let's keep hamburger and we don't want value management.
We want something better. I think there's a branding issue. I mean we have
not been able to talk about what's a better win.
Those are my last thoughts.
Josh. Really great conversation today.
I won't rehash what other committee members have said but maybe I'll just kind of roll up my comments
in a couple themes that I thought I heard today. I think several of our
panelists observed that some of the issues reflected in our white paper aren't
new and I think that's fair on one hand but actually I think that's part of the value of
memorializing what we've learned from the committee's work, from stakeholders across
healthcare and bringing them forward into the present and really using those lessons to
sharpen the conversation I think we need to have now. So for example I think many
thoughtful people including organizations and stakeholder groups represented today have been
working on these challenges for years. So noting them is important and yet the fact
that we continue to confront many of these same problems I think should prompt us, the Grand Us,
capital U, us to ask more directly what continues to stand in the way of progress.
I think a few panelists offered some suggestions but I think more is there and I think the
white paper has a key role in pushing that conversation forward.
And I think the other kind of, again, theme, kind of meta theme that I heard in
today's comments was really about, even though it wasn't stated explicitly, was the
distinction between kind of a flaw in a fundamental strategy for how
we pay for care versus a flaw in implementation of care, that
a payment approach or a model or an incentive in its full form
could be very good but we've implemented it poorly versus just even in its full form
it can't achieve the goals that we want. I think that, I'll push into that a little bit
more in my comments tomorrow but I think that's really critical here. And I think the
point here is that from my view the comments today helped me kind of realize that these
are the areas in which policy aspiration meet like operational reality
and I think our white paper can help us focus that conversation.
Another thing I heard from multiple people was that, you know, we're not about measuring participation,
we're not measuring outcomes, and this is true, but also participation
is necessary to achieve those outcomes and we still struggle with that. And a few of our panelists
noted the penetration issues that we have. So we just have to grapple with that reality.
Walter's points about,
you know, if models are sufficiently attractive, accessible, workable
we don't need mandates and yet I think all of us in our careers in healthcare know
that mandates are needed in some cases. And so we can't just say that
and as a nice concept and move on. The white paper, if it serves a value in surfacing
these things, although not new, although can't fix healthcare tomorrow, helps us grapple
with these things and I think we should stand in that moment here. Final kind of example of that
and then I'll stop is that, you know, there's some comments around things like burden in quality
reporting and measurements. And so I think that when we think about reform
I appreciated Mike Turner's comment about restraint and it's easy to say and very hard to do
but I think that the kind of regulatory safeguards we want to implement against
favorable selection or measurement distortion, et cetera, et cetera
can strengthen kind of a model's integrity, but each of those safeguards
adds reporting burdens, compliant costs, implementation friction, et cetera. So I think the
comments about simplicity is good, but even there we have to tussle with
you know, too much one way is not good. And these are good
concepts and aspirations, but just as Mike was mentioning with his example
of the PCMH, patient-centered medical home concepts around medical homes
that's great. When you start measuring and accrediting and credentialing people around that
it gets much harder. I think you'll find in each of the areas that I think that I've raised
today and many of the others from other committee members, that's where the hard work is
and I hope our paper in taking this feedback and refining that feedback can help
achieve that. So, you know, really great conversation, look forward to more.
David online? Yes, can you guys hear me okay?
Yeah, hey David, go ahead. Yeah, I think
obviously I was unable to join this morning, but the afternoon sessions
were excellent and I thought that the thing that really stood out
to me was Elizabeth Mitchell's comments around
urgency, the affordability challenges
that are out there right now, the overwhelming narrative
that has sort of taken hold of Washington, rightfully
so around affordability creates this sense of urgency and I think she's
absolutely right that a 10-year horizon
is not something that people are going to be able to tolerate
and I think also kind of piggybacking on what other folks have noted
is I think the reassuring thing is
obviously our sample size today
is all people who believe and support value-based care, so
not exactly a perfect sample, but I think there is
overwhelming agreement. I think that we're arguing around
the margins, there's different ways to accomplish these things, but I think fundamentally
the goals are shared and I think that
what is really, you know,
interesting is that you have people on there who have
been even on this committee and have been talking about these things for 10 years. I mean,
to Josh's point, I think that that is actually
a positive, that we know
a lot of what the answers need to be. It's a matter of actually
executing on them and so I hope that we can continue talking about
that and I've seen that play out here
at my health system where I work. I've been saying some version
of these same diatribes about how we need to shift to
value and try to get buy-in at the physician level and all
this stuff since I got here in 2017, so it's certainly
not anything new, but I don't think that's necessarily
a bug. It probably is a feature, so
I've enjoyed the conversations this afternoon and look forward to tomorrow.
Thank you, David. So I'm not going to
repeat, I guess, the extensive insight that the committee's
provided. The day was surprising to me
to some degree because if I had to sum it up,
the concept that we need, one,
there was obviously a lot of agreement that we need the value-based care is important,
it's where we need to go and that's the direction, but the theme
around deconstructing what exists versus
reconstructing or constructing new things was what I
took away. The second theme was obviously reinvesting
in primary care in a version that incentivized
continuity and not necessarily
in a version that separated out different types of primary care but just
incentivized more global continuity as a mechanism
for quality and then deconstructing quality.
The other major theme that I saw, and this is probably the last
that I'll add, is the concept that we
do need to treat different geographies differently.
This has come up before, but to the drastic
extent that was articulated today surprised me.
In rural, we really do need to have a significant
amount, 90 plus percent, which I don't know if we'll do,
but a significant amount of prospective payment
without extensive quality gating, without extensive
regulation. Deconstruct everything in its
current form and hold people accountable to obviously
a value-based care alternative payment mechanism. Then why
it's speaking to it, you have to up the incentives for
large hospital systems which largely exist in urban areas
and throw more money into it.
In a budget neutral environment, that's a higher percentage of money that then
you're attributing towards certain value-based care
initiatives and taking it away from procedural initiatives. It's a drastic shift
in how the American healthcare system is paid.
I'm using
broad strokes, but those are the elements of today that surprised me.
I'll stop there.
I also heard what I think is
a quantitative opportunity, Steve, and I'm aware
that we have Akashic and I'm not afraid to use them, but
put this in the hopper for when we can get to it.
Dr. Pham talked about voluntary models will
always underrepresent the highest cost providers,
and I get it. That feels quantitative.
We get back in the data set and say imagine the published ACO,
like next-gen savings. Imagine if those
geographic areas penetration was not what it was who participated
but it was 80% of the market including all the
higher cost providers who didn't participate. What would the savings
with the appropriately increased benchmark representing
the geography truly have been? What would the published savings have been then?
I think that's a really fast and that feels quantitative.
Akashic, between 2 and 3 a.m. is still free on your schedule.
At this time, I want to thank everyone for participating
today. Our wonderful session experts, my PTAC colleagues, and those who
joined us in person and online to listen. We'll be back tomorrow
at 9 a.m. Eastern Time. We'll be joined by four incredible experts who
share their perspective and input during the session on PTAC's draft
white paper, Transforming Healthcare Delivery through Value-Based Care
Payment Models in Care, a Roadmap. There will also be
an opportunity for public comments related to the meeting topic tomorrow morning at
10.50 a.m. Eastern Time before the meeting concludes with
the committee discussion. We hope you'll join us and thank you. This meeting
is adjourned for the day.